Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Study to Assess Safety, Immunogenicity and Parasite Growth Inhibition of an Asexual Blood Stage Vaccine for P. Falciparum Malaria

This study has been completed.
Sponsor:
Collaborator:
Information provided by:
University of Oxford
ClinicalTrials.gov Identifier:
NCT00984763
First received: September 24, 2009
Last updated: March 25, 2011
Last verified: March 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2010
  Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
No publications provided by University of Oxford

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):